Philipp W. Raess

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported”.

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Blood Advances(2021)10.1182/bloodadvances.2021004983

N/A

0DataRank · unranked

6 citations

Matthew M. Klairmont, Joel F. Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra +11 more

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab

British Journal of Haematology(2023)10.1111/bjh.19153

N/A

0DataRank · unranked

5 citations

Allison Rosenthal, Ryan S. Robetorye, Raphael Mwangi, Matthew J. Maurer, Diego Villa +20 more

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

Blood Cancer Journal(2025)10.1038/s41408-025-01236-6

N/A

0DataRank · unranked

12 citations

Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond +40 more